This site is intended for healthcare professionals only
LoginRegister

Cardiology-CTVS Dialogues

Intravenous tolvaptan equally safe and effective as oral formulation in severe acute heart failure patients: Study

Intravenous tolvaptan equally safe and effective as oral formulation in severe acute heart failure...

Japan: In a new study focusing on the management of acute decompensated heart failure (ADHF), researchers have compared the efficacy and safety of...
View All

Latest News and Guidelines

SGLT2i Versus DPP-4i as an Add-On Therapy and the Risk of PAD-Related Surgical Events

Semaglutide Shines in Kidney Health Across Diabetes Patients: Study Highlights Consistency and...

Lipid-Lowering Therapies Could Reduced Risk of Venous Thromboembolism: Study

Lipid-Lowering Therapies Could Reduced Risk of Venous Thromboembolism: Study

USFDA approves Tonix Pharma Tonmya for fibromyalgia in adults

Zydus Lifesciences BP lowering drug receives USFDA tentative nod

Cardiological Society of India releases first Indian guidelines for Dyslipidemia Management

Cardiological Society of India releases first Indian guidelines for Dyslipidemia Management

Evaluating the Benefits of Aspirin in Lowering ASCVD Mortality for Elevated Lp(a) Individuals

Evaluating the Benefits of Aspirin in Lowering ASCVD Mortality for Elevated Lp(a) Individuals

CDSCO Eases Rules for Biopharma Research, Will Accept Lab Biosafety Committee Approvals

American Heart Association Advocates Genetic Testing to Personalize Oral P2Y12 Inhibitor Therapy for...

View All
X